MJ Nutra Recalls Champignons et Adaptogènes Due to Ingredient Concentration Discrepancies
Areazine synthesizes this Health Canada recall directly from Health Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
MJ Nutra has issued a recall for a specific lot of Champignons et Adaptogènes powder because the concentration of certain ingredients does not match the product label.
What this Health Canada recall tells you, and what most readers miss
This notice was issued by Health Canada on April 6, 2026 and geographically references Canada. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Product & Food Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, health-canada, HealthProduct.
What Happened
MJ Nutra has initiated a recall for one lot of its health product, Champignons et Adaptogènes. The recall was issued because the affected lot contains concentrations of certain ingredients that differ from the concentrations listed on the product label. This discrepancy was identified during a review of the product's lot-specific data.
Which Products Are Affected
The recall specifically impacts the following product:
- Brand: MJ Nutra
- Product Name: Champignons et Adaptogènes
- Market Authorization (NPN): 80139467
- Dosage Form: Powder
- Affected Lot: 225107
- Labelled Ingredients: Astragalus membranaceus (472.5 mg), Eleutherococcus senticosus (940.0 mg), Ganoderma lucidum (200.0 mg), Hericium erinaceus (610.0 mg), Lepidium meyenii (1.89 g), Lycium barbarum (610.0 mg), Paecilomyces hepialid (710.0 mg), Panax ginseng (140.0 mg), Phyllanthus emblica (140.0 mg), Rhodiola rosea (410.0 mg), and Withania somnifera (2.65 g).
What You Should Do
Consumers are advised to verify if their product belongs to the affected lot (225107). Health Canada recommends consulting a healthcare provider before discontinuing the use of the product or if you have any health concerns related to its consumption.
For questions regarding the recall, consumers can contact MJ Nutra at 1335 rue René-Descartes, Saint-Bruno, QC, J3V 0B7. Any health product-related side effects or safety complaints should be reported directly to Health Canada.
Why This Matters
When the actual concentration of ingredients in a health supplement differs from the label, consumers may unknowingly ingest incorrect dosages. This can lead to unexpected side effects or a lack of intended therapeutic benefit.
Source
For more information, visit the official Health Canada recall notice.
Original source: Health Canada Official Notice ↗
Related Product & Food Recalls
All Product & Food Recalls →Frequently Asked Questions
Common questions about this Health Canada recall.